Cargando…

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets

Detalles Bibliográficos
Autores principales:	Kawajiri, Masakazu, Koge, Junpei, Hashimoto, Tetsuya, Yamada, Takeshi, Isobe, Noriko, Kira, Jun-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460294/ https://www.ncbi.nlm.nih.gov/pubmed/31011635 http://dx.doi.org/10.1016/j.ensci.2019.100190

Ejemplares similares

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ(®) tablets
por: Vitiello, Gianfranco, et al.
Publicado: (2020)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed
por: Mösges, Ralph, et al.
Publicado: (2021)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Erratum: In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2017)

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets
por: Yamamoto, Takashi, et al.
Publicado: (2022)

Treatment of Patients with Refractory Atopic Dermatitis Sensitized to House Dust Mites by Using Sublingual Allergen Immunotherapy
por: Choi, Joon-Seok, et al.
Publicado: (2015)

Immunotherapy – 2074. Tolerability of sublingual immunotherapy with tropical mite allergen vaccines using different dosing schedules in asthmatic children
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Sublingual immunotherapy for pediatric patients with mite allergies
por: Kajiume, Teruyuki
Publicado: (2022)

O17 - Assessment of efficacy and safety of sublingual tablets of house dust mite allergen extract in children and adolescents with allergic rhinitis
por: Halken, Susanne, et al.
Publicado: (2014)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019)

Long-term effects of allergen sublingual immunotherapy
por: Bozek, Andrzej, et al.
Publicado: (2019)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

Commentary: Sublingual Allergen Immunotherapy in HIV-Positive Patients
por: Chirumbolo, Salvatore
Publicado: (2016)

487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
por: Alvarez, Mirta, et al.
Publicado: (2012)

Acute systemic reactions to sublingual immunotherapy for house dust mite
por: Janssens, Nicky S., et al.
Publicado: (2020)

Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
por: Abu El‐Enin, Mohammed A., et al.
Publicado: (2022)

159 Therapeutic Effect and Safety of the Sublingual Immunotherapy With Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patients
por: Castro Almarales, Raúl Lázaro, et al.
Publicado: (2012)

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen
por: Aliu, Have, et al.
Publicado: (2017)

Sublingual allergen immunotherapy for respiratory allergy: a systematic review
por: Blanco, Carlos, et al.
Publicado: (2018)

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy
por: Moral, Angel, et al.
Publicado: (2016)

Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children
por: Lim, Jae Hyun, et al.
Publicado: (2017)

200 Efficacy of Mite Sublingual Immunotherapy in 130 Children with Atopic Dermatitis
por: Tang, Jianping
Publicado: (2012)

Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy
por: Aarestrup, Matheus Fonseca, et al.
Publicado: (2021)

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
por: Quirt, J., et al.
Publicado: (2018)

Assessment of stability and compatibility of dermatophagoides and blomia allergen mixture for sublingual immunotherapy
por: Morejón, Maytee Mateo, et al.
Publicado: (2015)

Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety
por: Abdelwahab, Heba Wagih, et al.
Publicado: (2023)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

Characteristics of dust mite sublingual immunotherapy-associated adverse events in the early phase
por: Chen, Ming, et al.
Publicado: (2022)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells
por: Pelst, Michael P., et al.
Publicado: (2020)

Sublingual Immunotherapy: How Sublingual Allergen Administration Heals Allergic Diseases; Current Perspective about the Mode of Action
por: Gotoh, Minoru, et al.
Publicado: (2021)

Immunotherapy – 2072. Therapeutic effect and higher safety profile for allergic asthma in Cuban patients with sublingual immunmotherapy using tropical domestic mite allergen vaccines
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Observation on the efficacy of sublingual immunotherapy with dust mite allergen for perennial allergic rhinitis and the mechanism of action on ILCs with ILC1s and ILC2s and ILC3s
por: Tang, Guangjun, et al.
Publicado: (2022)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_73ep9bisc3q2lcqjlglckpgukg